| Typicality: | 0.478 |
| Saliency: | 0.345 |
| currently | 6 | temporal |
| as a treatment for glioblastoma | 6 | purpose |
| in order to understand its true effectiveness | 3 | purpose |
| drug → be used in → clinical trials | 28 |
| drug → be used in → clinical trial | 6 |
| drug → be used for → clinical trials | 3 |
| drug → be used in → clinical study | 3 |
| negative | neutral | positive |
| 0.111 | 0.637 | 0.252 |
| Raw frequency | 40 |
| Normalized frequency | 0.345 |
| Modifier score | 0.750 |
| Perplexity | 94.430 |